glp-1 news nov 2025 Retailers across the country are noticing a spike in returns of clothing as more Americans embrace drugs for weight loss. The rate of retail exchanges where shoppers traded clothing for a GLP-1 Weight-Loss Drug Demonstration Begins

Patients using GLP-1 receptor agonists are reporting something unexpected: less joint and musculoskeletal pain

For that same 220-pound person, that means losing approximately 63 pounds, nearly double what semaglutide delivers

Individual body chemistry determines tolerance more than the medication choice

PlexusDx providers evaluate your complete surgical history, current digestive symptoms, and any post-cholecystectomy complications to determine whether compounded semaglutide is appropriate and what baseline monitoring is needed

Thus, there has been limited progress in developing pharmacological interventions for obesity-diabetes that leverage the metabolic effects of GIP